Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 7 de 7
1.
Science ; 360(6388): 508-513, 2018 05 04.
Article En | MEDLINE | ID: mdl-29724949

Small-conductance Ca2+-activated K+ (SK) channels mediate neuron excitability and are associated with synaptic transmission and plasticity. They also regulate immune responses and the size of blood cells. Activation of SK channels requires calmodulin (CaM), but how CaM binds and opens SK channels has been unclear. Here we report cryo-electron microscopy (cryo-EM) structures of a human SK4-CaM channel complex in closed and activated states at 3.4- and 3.5-angstrom resolution, respectively. Four CaM molecules bind to one channel tetramer. Each lobe of CaM serves a distinct function: The C-lobe binds to the channel constitutively, whereas the N-lobe interacts with the S4-S5 linker in a Ca2+-dependent manner. The S4-S5 linker, which contains two distinct helices, undergoes conformational changes upon CaM binding to open the channel pore. These structures reveal the gating mechanism of SK channels and provide a basis for understanding SK channel pharmacology.


Calmodulin/chemistry , Intermediate-Conductance Calcium-Activated Potassium Channels/chemistry , Acetamides/chemistry , Calmodulin/agonists , Calmodulin/ultrastructure , Cryoelectron Microscopy , Humans , Intermediate-Conductance Calcium-Activated Potassium Channels/agonists , Intermediate-Conductance Calcium-Activated Potassium Channels/ultrastructure , Potassium Channel Blockers/chemistry , Protein Domains , Thiazines/chemistry , Trityl Compounds/chemistry
2.
Toxicol Lett ; 260: 18-27, 2016 Oct 17.
Article En | MEDLINE | ID: mdl-27558804

The heavy metal cadmium is a widespread environmental contaminant that has gained public attention due to the global increase in cadmium-containing electronic waste. Human exposure to cadmium is linked to the pathogenesis of osteoporosis. We previously reported cadmium induces apoptosis and decreases alkaline phosphatase mRNA expression via extracellular signal-regulated protein kinase (ERK) activation in Saos-2 bone-forming osteoblasts. This study examines the mechanisms of cadmium-induced osteotoxicity by investigating roles of Ca+2/calmodulin-dependent protein kinase (CAMK) pathways. Saos-2 or MG-63 cells were treated for 24 or 48h with 5µM CdCl2 alone or in combination with calmodulin-dependent phosphodiesterase (PDE) inhibitor CGS-9343ß; calmodulin-dependent kinase kinase (CAMKK) inhibitor STO-609; or calmodulin-dependent kinase II (CAMKII) inhibitor KN-93. CGS-9343ß protected against cadmium-induced toxicity and attenuated ERK activation; STO-609 enhanced toxicity and exacerbated ERK activation, whereas KN-93 had no detectable effect on cadmium-induced toxicity. Furthermore, CGS-9343ß co-treatment attenuated cadmium-induced apoptosis; but CGS-9343ß did not recover cadmium-induced decrease in ALP activity. The major findings suggest the calmodulin-dependent PDE pathway facilitates cadmium-induced ERK activation leading to apoptosis, whereas the CAMKK pathway plays a protective role against cadmium-induced osteotoxicity via ERK signaling. This research distinguishes itself by identifying pleiotropic roles for CAMK pathways in mediating cadmium's toxicity in osteoblasts.


Apoptosis/drug effects , Cadmium/toxicity , Calcium Signaling/drug effects , Calcium-Calmodulin-Dependent Protein Kinase Kinase/metabolism , Cyclic Nucleotide Phosphodiesterases, Type 1/metabolism , Environmental Pollutants/toxicity , Osteoblasts/drug effects , Benzimidazoles/pharmacology , Benzylamines/pharmacology , Biomarkers/metabolism , Cadmium/agonists , Cadmium/chemistry , Calcium-Calmodulin-Dependent Protein Kinase Kinase/antagonists & inhibitors , Calcium-Calmodulin-Dependent Protein Kinase Kinase/chemistry , Calcium-Calmodulin-Dependent Protein Kinase Type 2/antagonists & inhibitors , Calcium-Calmodulin-Dependent Protein Kinase Type 2/chemistry , Calcium-Calmodulin-Dependent Protein Kinase Type 2/metabolism , Calmodulin/agonists , Calmodulin/antagonists & inhibitors , Calmodulin/metabolism , Cell Line, Tumor , Cyclic Nucleotide Phosphodiesterases, Type 1/antagonists & inhibitors , Cyclic Nucleotide Phosphodiesterases, Type 1/chemistry , Environmental Pollutants/agonists , Environmental Pollutants/antagonists & inhibitors , Enzyme Activation/drug effects , Humans , Lethal Dose 50 , MAP Kinase Signaling System/drug effects , Naphthalimides/pharmacology , Osteoblasts/enzymology , Osteoblasts/metabolism , Phosphodiesterase Inhibitors/pharmacology , Protein Kinase Inhibitors/pharmacology , Sulfonamides/pharmacology
3.
Cardiovasc Res ; 96(3): 533-42, 2012 Dec 01.
Article En | MEDLINE | ID: mdl-22886848

AIMS: Restenosis is an undesirable consequence following percutaneous vascular interventions. However, the current strategy for preventing restenosis is inadequate. The aim of this study was to investigate the role of low-voltage gated T-type calcium channels in regulating vascular smooth muscle cell (VSMC) proliferation during neointimal formation. METHODS AND RESULTS: Wire injury of mice carotid arteries resulted in neointimal formation in the wild-type and Ca(v)3.2(-/-) but not Ca(v)3.1(-/-) mice, indicating a critical role of Ca(v)3.1 in neointimal formation. In addition, we found a significant increase of Ca(v)3.1 mRNA and protein in injured arteries. Ca(v)3.1 knockout or knockdown (shCa(v)3.1) reduced VSMC proliferation. Since T-channels are expressed predominantly in the G(1) and S phases in VSMCs, we examined whether an abnormal G(1)/S transition was the cause of the reduced cell proliferation in shCa(v)3.1 VSMCs. We found a disrupted expression of cyclin E in shCa(v)3.1 VSMCs, and calmodulin agonist CALP1 partially rescued the defective cell proliferation. Furthermore, we demonstrated that infusion of NNC55-0396, a selective T-channel blocker, inhibited neointimal formation in wild-type mice. CONCLUSION: Ca(v)3.1 is required for VSMC proliferation during neointimal formation, and blocking of Ca(v)3.1 may be beneficial for preventing restenosis.


Calcium Channels, T-Type/metabolism , Carotid Arteries/metabolism , Carotid Artery Injuries/metabolism , Muscle, Smooth, Vascular/metabolism , Myocytes, Smooth Muscle/metabolism , Neointima , Vascular System Injuries/metabolism , Animals , Benzimidazoles/pharmacology , Calcium Channel Blockers/pharmacology , Calcium Channels, T-Type/deficiency , Calcium Channels, T-Type/drug effects , Calcium Channels, T-Type/genetics , Calmodulin/agonists , Calmodulin/metabolism , Carotid Arteries/pathology , Carotid Artery Injuries/genetics , Carotid Artery Injuries/pathology , Cell Cycle Checkpoints , Cell Proliferation , Cells, Cultured , Cyclin E/metabolism , Cyclopropanes/pharmacology , Disease Models, Animal , Gene Expression Regulation , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Muscle, Smooth, Vascular/drug effects , Muscle, Smooth, Vascular/injuries , Muscle, Smooth, Vascular/pathology , Myocytes, Smooth Muscle/drug effects , Myocytes, Smooth Muscle/pathology , Naphthalenes/pharmacology , Oligopeptides/pharmacology , RNA Interference , RNA, Messenger/metabolism , Time Factors , Transfection , Vascular System Injuries/genetics , Vascular System Injuries/pathology
4.
Differentiation ; 84(2): 163-75, 2012 Sep.
Article En | MEDLINE | ID: mdl-22595345

Ca(2+) regulates cell differentiation and morphogenesis in a diversity of organisms and dysregulation of Ca(2+) signal transduction pathways leads to many cellular pathologies. In Dictyostelium Ca(2+) induces ecmB expression and stalk cell differentiation in vitro. Here we have analyzed the pattern of ecmB expression in intact and bisected slugs and the effect of agents that affect Ca(2+) levels or antagonize calmodulin (CaM) on this expression pattern. We have shown that Ca(2+) and CaM regulate ecmB expression and pstAB/pstB cell differentiation in vivo. Agents that increase intracellular Ca(2+) levels increased ecmB expression and/or pstAB and pstB cell differentiation, while agents that decrease intracellular Ca(2+) or antagonize CaM decreased it. In isolated slug tips agents that affect Ca(2+) levels and antagonize CaM had differential effect on ecmB expression and cell differentiation in the anterior versus posterior zones. Agents that increase intracellular Ca(2+) levels increased the number of ecmB expressing cells in the anterior region of slugs, while agents that decrease intracellular Ca(2+) levels or antagonize CaM activity increased the number of ecmB expressing cells in the posterior. We have also demonstrated that agents that affect Ca(2+) levels or antagonize CaM affect cells motility and regeneration of shape in isolated slug tips and backs and regeneration of tips in isolated slug backs. To our knowledge, this is the first study detailing the pattern of ecmB expression in regenerating slugs as well as the role of Ca(2+) and CaM in the regeneration process and ecmB expression.


Calcium Signaling , Calcium/metabolism , Dictyostelium/growth & development , Extracellular Matrix Proteins/metabolism , Protozoan Proteins/metabolism , Regeneration , Calcimycin/pharmacology , Calmodulin/agonists , Calmodulin/antagonists & inhibitors , Calmodulin/metabolism , Dictyostelium/cytology , Dictyostelium/metabolism , Egtazic Acid/analogs & derivatives , Egtazic Acid/pharmacology , Extracellular Matrix Proteins/genetics , Gene Expression Regulation, Developmental , Hydroquinones/pharmacology , Macrolides/pharmacology , Protozoan Proteins/genetics , Regeneration/drug effects , Sulfonamides/pharmacology , Verapamil/pharmacology
5.
J Recept Signal Transduct Res ; 27(1): 47-65, 2007.
Article En | MEDLINE | ID: mdl-17365509

The Ca2+ sensor calmodulin (CaM) regulates numerous proteins involved in G protein-coupled receptor (GPCR) signaling. CaM binds directly to some GPCRs, including the dopamine D2 receptor. We confirmed that the third intracellular loop of the D2 receptor is a direct contact point for CaM binding using coimmunoprecipitation and a polyHis pull-down assay, and we determined that the D2-like receptor agonist 7-OH-DPAT increased the colocalization of the D2 receptor and endogenous CaM in both 293 cells and in primary neostriatal cultures. The N-terminal three or four residues of D2-IC3 were required for the binding of CaM; mutation of three of these residues in the full-length receptor (I210C/K211C/I212C) decreased the coprecipitation of the D2 receptor and CaM and also significantly decreased D2 receptor signaling, without altering the coupling of the receptor to G proteins. Taken together, these findings suggest that binding of CaM to the dopamine D2 receptor enhances D2 receptor signaling.


Calmodulin/metabolism , Calmodulin/pharmacology , Receptors, Dopamine D2/metabolism , Signal Transduction , Amino Acid Motifs , Amino Acid Sequence , Binding Sites , Calmodulin/agonists , Cell Line , Colforsin/pharmacology , Cyclic AMP/metabolism , Extracellular Signal-Regulated MAP Kinases/metabolism , Humans , Molecular Sequence Data , Neostriatum/cytology , Neostriatum/metabolism , Neurons/metabolism , Receptors, Dopamine D2/genetics , Transfection
6.
Brain Res Bull ; 67(3): 225-34, 2005 Oct 15.
Article En | MEDLINE | ID: mdl-16144659

Defects in proteasome function have been suggested to be involved in the pathogenesis of neurodegenerative diseases. We examined the effect of calmodulin antagonists on proteasome inhibitor-induced mitochondrial dysfunction and cell viability loss in undifferentiated PC12 cells. Caspase inhibitors (z-IETD.fmk, z-LEHD.fmk and z-DQMD.fmk) and antioxidants attenuated cell death and decrease in GSH contents in PC12 cells treated with 20 microM MG132, a proteasome inhibitor. Calmodulin antagonists (trifluoperazine, W-7 and calmidazolium) had a differential inhibitory effect on the MG132-induced cell death and GSH depletion depending on concentration with a maximal inhibitory effect at 0.5-1 microM. Addition of trifluoperazine and W-7 reduced the MG132-induced nuclear damage, loss of the mitochondrial transmembrane potential followed by cytochrome c release, formation of reactive oxygen species and elevation of intracellular Ca(2+) levels in PC12 cells. Calmodulin antagonists at 5 microM exhibited a cytotoxic effect on PC12 cells but attenuated the cytotoxicity of MG132. The results suggest that the toxicity of MG132 on PC12 cells is mediated by activation of caspase-8, -9 and -3. Trifluoperazine and W-7 at the concentrations of 0.5-1 microM may attenuate the MG132-induced viability loss in PC12 cells by suppressing change in the mitochondrial membrane permeability and by lowering of the intracellular Ca(2+) levels as well as calmodulin inhibition.


Calmodulin/agonists , Enzyme Inhibitors/pharmacology , Imidazoles/pharmacology , Leupeptins , Mitochondrial Diseases/prevention & control , Animals , Calcium/metabolism , Caspase 3 , Caspases/metabolism , Cell Count/methods , Cell Death/drug effects , Cell Size/drug effects , Cell Survival/drug effects , Cytochromes c/metabolism , Dose-Response Relationship, Drug , Drug Interactions , Glutathione/metabolism , Mitochondrial Diseases/chemically induced , PC12 Cells , Rats , Reactive Oxygen Species/metabolism , Sulfonamides/pharmacology , Trifluoperazine/pharmacology
7.
Biochem Biophys Res Commun ; 277(2): 462-9, 2000 Oct 22.
Article En | MEDLINE | ID: mdl-11032745

We have used the method of inverted hydropathy to develop peptides that interact with EF hands of calmodulin (CaM). Previously we have shown these peptides specifically interact with their desired target in a productive manner, in that they activated CaM in the absence of Ca(2+). Therefore, we sought to determine whether these peptides would enter cells, remain intact, and interact with CaM in the interior of the cell. Using several techniques we have demonstrated cellular uptake, stability, and an intracellular interaction with CaM with fluorescein-labeled and radiolabeled peptides in Jurkat T cells. The results suggest that these peptides may be useful in the study and the manipulation of Ca(2+)-mediated pathways in cells.


Calmodulin/agonists , Calmodulin/chemistry , Peptides/chemistry , Animals , Blotting, Western , Calcium/metabolism , Calmodulin/metabolism , Cattle , Cells, Cultured , Chromatography, High Pressure Liquid , Cross-Linking Reagents/pharmacology , Dose-Response Relationship, Drug , Fluorescein/pharmacology , Humans , Jurkat Cells , Kinetics , Microscopy, Fluorescence , Peptides/metabolism , Peptides/pharmacokinetics , Phosphoric Diester Hydrolases/metabolism , Precipitin Tests , Protein Binding , Signal Transduction , Subcellular Fractions , Temperature , Time Factors
...